TD Asset Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

TD Asset Management’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-13,000	Closed	-$313K	–	1375
2014 Q2	$313K	Sell	13,000 -151,800	-92%	-$1.58M	﹤0.01%	1137
2014 Q1	$994K	Sell	164,800 -13,500	-8%	-$94.1K	﹤0.01%	907
2013 Q4	$1.07M	Sell	178,300 -33,500	-16%	-$155K	﹤0.01%	879
2013 Q3	$1.1M	Buy	211,800 +17,900	+9%	+$78.4K	﹤0.01%	858
2013 Q2	$700K	Buy	+193,900	New	+$793K	﹤0.01%	883

TD Asset Management's IDIX Position: Q3 2014 in Review

TD Asset Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 13,000 shares — an estimated $313K sold.

TD Asset Management first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $1.1M in Q3 2013. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

TD Asset Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
TD Asset Management sold 13,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $313K.
TD Asset Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
TD Asset Management's IDENIX PHARMACEUTICALS INC position peaked at $1.1M in Q3 2013.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on TD Asset Management's 13F filing for Q3 2014, filed 6 Nov 2014.